Division of Infectious Diseases
-
March 30, 2022
New Clinician Spotlight: Rebecca (Ribka) Berhanu
Rebecca Berhanu, MD, assistant professor of Medicine, has joined Vanderbilt's Division of Infectious Diseases as a clinician and researcher. -
March 17, 2022
Blood test figures in cancer risk for people with HIV
A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer. -
March 17, 2022
Talbot named to infection prevention society’s leadership
Vanderbilt's Tom Talbot, MD, MPH, was recently elected to serve in the leadership of the Society for Healthcare Epidemiology of America. -
March 16, 2022
Teamwork returns man with severe post-COVID complications to his life
A multidisciplinary team at Vanderbilt helped José Ontiveros cope with a long list of severe complications arising from his COVID-19i infection. -
March 14, 2022
Microbiome reflects COVID-19 severity
Characterization of the upper respiratory tract microbiome could help predict outcomes for COVID-19 infection, Vanderbilt researchers have discovered. -
February 28, 2022
Invasive strep can defy zinc toxicity
Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels. -
January 24, 2022
Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines
Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children.